MY-COMP, an inhibitor of the transcriptional activity of YAP-B-MYB, identifies NEK2 as a novel mediator of YAP oncogenesis in uveal melanoma cells
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 29 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Uveal melanomaThis series is part of our curated briefing on it.
- Samples
- 29 samples: 7 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancersOncogene · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE227974_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA947598 and SRA study SRP428755. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 21 samples.
How we read this: 7 replicated groups read from 29 sample titles; they account for 21 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7111604 CnR3_IgG
- GSM7111605 CnR3_H3K4me3
- GSM7111606 CnR3_H3K27ac
- GSM7111607 CnR4_IgG
- GSM7111608 CnR4_H3K4me1
- GSM7111609 CnR8_IgG_merged
- GSM7111610 CnR8_H4ac
- GSM7111611 CnR8_YAP
- GSM7111612 RNAseq_92_1_siCtrl_rep1 RNAseq_92_1_siCtrl
- GSM7111613 RNAseq_92_1_siCtrl_rep2 RNAseq_92_1_siCtrl
- GSM7111614 RNAseq_92_1_siCtrl_rep3 RNAseq_92_1_siCtrl
- GSM7111615 RNAseq_92_1_siYAP_rep1 RNAseq_92_1_siYAP
- GSM7111616 RNAseq_92_1_siYAP_rep2 RNAseq_92_1_siYAP
- GSM7111617 RNAseq_92_1_siYAP_rep3 RNAseq_92_1_siYAP
- GSM7111618 RNAseq_92_1_MY_COMP_rep1 RNAseq_92_1_MY_COMP
- GSM7111619 RNAseq_92_1_MY_COMP_rep2 RNAseq_92_1_MY_COMP
- GSM7111620 RNAseq_92_1_MY_COMP_rep3 RNAseq_92_1_MY_COMP
- GSM7111621 RNAseq_MCF10A_noDox_noOHT_rep1 RNAseq_MCF10A_noDox_noO…
- GSM7111622 RNAseq_MCF10A_noDox_noOHT_rep2 RNAseq_MCF10A_noDox_noO…
- GSM7111623 RNAseq_MCF10A_noDox_noOHT_rep3 RNAseq_MCF10A_noDox_noO…
- GSM7111624 RNAseq_MCF10A_noDox_withOHT_rep1 RNAseq_MCF10A_noDox_wit…
- GSM7111625 RNAseq_MCF10A_noDox_withOHT_rep2 RNAseq_MCF10A_noDox_wit…
- GSM7111626 RNAseq_MCF10A_noDox_withOHT_rep3 RNAseq_MCF10A_noDox_wit…
- GSM7111627 RNAseq_MCF10A_withDox_noOHT_rep1 RNAseq_MCF10A_withDox_n…
- GSM7111628 RNAseq_MCF10A_withDox_noOHT_rep2 RNAseq_MCF10A_withDox_n…
- GSM7111629 RNAseq_MCF10A_withDox_noOHT_rep3 RNAseq_MCF10A_withDox_n…
- GSM7111630 RNAseq_MCF10A_withDox_withOHT_rep1 RNAseq_MCF10A_withDox_w…
- GSM7111631 RNAseq_MCF10A_withDox_withOHT_rep2 RNAseq_MCF10A_withDox_w…
- GSM7111632 RNAseq_MCF10A_withDox_withOHT_rep3 RNAseq_MCF10A_withDox_w…
- GSE196624 The role of EHMT2 in Uveal melanoma progression [EHMT2_Inhibitors] 18 samples same disease briefing · shares inhibitor
- GSE231396 PRAME induces genomic instability in uveal melanoma 23 samples same disease briefing
- GSE267153 Systems modeling of oncogenic G-protein and oncogenic GPCR signaling reveals unexpected differences in downstream signaling pathway activation [FAKi_experiment] 27 samples same disease briefing
- GSE329420 Endothelial exosomes remodel chromatin accessibility and superenhancer in cancer cells to promote liver metastatic colonization 26 samples same disease briefing
- GSE294950 Epigenetic library screen reveals novel targets for uveal melanoma 24 samples same disease briefing
- GSE317536 Matched sampling reveals uncoupled phenotypic plasticity during metastasis formation in uveal melanoma 23 samples same disease briefing
- GSE271539 H3K9ac and H3K27ac analysis of 92.1-parental and 92.1-resistant uveal melanoma cells 16 samples same disease briefing
- GSE312967 The transcriptome and miRNA expression profiles of SOX10-knockdown uveal melanoma 16 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.